Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Influenza
52%
COVID-19
51%
Vaccine Efficacy
44%
Influenzavirus A
39%
Antibody Response
24%
Viral Replication
24%
Neutralizing Antibody
24%
Cell Culture
23%
Vaccination Policy
23%
Blood Plasma
22%
Spike
22%
Monospecific Antibody
20%
Viral Disease
20%
Influenza Virus
19%
Omicron Coronavirus Variant
17%
Virus Infectivity
15%
Influenza A Virus (H3N2)
15%
Hemagglutinin
13%
Mouse
13%
Titer
12%
Neutralization
11%
Epitope
11%
Influenza A Virus (H1N1)
11%
Transplant Procedure
10%
Immune Response
10%
Syrian Hamster
10%
SARS Coronavirus
10%
Viral Load
10%
Lineages
9%
T Cell
9%
Antibody Titer
9%
Cladistics
8%
interferon
8%
Virology
8%
Influenza Vaccine
7%
Receptor Binding
7%
Dynamics
7%
Wild Type
7%
Human Respiratory Syncytial Virus
6%
Virus Particle
6%
Glycoprotein
6%
Influenza C Virus
6%
Virus Strain
6%
Infectious Agent
5%
Coronavirinae
5%
Breakthrough Infection
5%
Respiratory Virus
5%
Gene Expression
5%
Hamster Model
5%
Keyphrases
COVID-19
55%
Influenza Virus
28%
Virus
25%
Influenza
16%
Convalescent Plasma
15%
Antibody Response
11%
Epithelial Cell Culture
11%
SARS-CoV-2 Infection
9%
Virus Replication
8%
Human Nasal Epithelial Cells
8%
Influenza-like Illness
7%
COVID-19 Pandemic
7%
Vaccination
7%
M2 Protein
7%
United States
7%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
7%
Neutralizing Antibodies
7%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
6%
Hemagglutinin
6%
Severe Acute Respiratory Syndrome Coronavirus 2 Variants
6%
Virology
6%
Rural Zambia
6%
Syrian Hamster
6%
High Titer
5%
COVID-19 Convalescent Plasma
5%
Infectious Virus
5%
Virus Infection
5%
Respiratory Syncytial Virus
5%
Hospitalization
5%
Zika Virus
5%
H1N1
5%
Healthcare Workers
5%
Disease Severity
5%
Virus-neutralizing Antibody
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
73%
COVID-19
56%
Infection
40%
Disease
12%
Antibody Response
11%
Neutralizing Antibody
11%
Symptom
10%
Outpatient
10%
Virus Infectivity
9%
Virus Infection
7%
Epithelial Cell
7%
Influenza Virus
7%
Immune Response
6%
Cell Culture
6%
Influenza Vaccine
6%
Emergency Department
6%
Public Health
6%
Antivirus Agent
6%
Virus Replication
5%
Virus RNA
5%
Adverse Event
5%
Omicron Coronavirus Variant
5%
Respiratory Tract Infection
5%